NTRK1 and skin basal cell carcinoma: As it was shown that CYLD can interfere with Trk signaling [53], although it is not entirely clear how loss of CYLD can promote overexpression of TrkC, a block of TRK receptor signaling has been proposed to represent a novel therapeutic target in tumors with loss of CYLD function including BCC [53].